Vincenzo Adamo
- Oncology top 1%
- Cancer Treatment and Pharmacology 21
- HER2/EGFR in Cancer Research 20
- Colorectal Cancer Treatments and Studies 14
- Lung Cancer Research Studies 14
- Cancer Immunotherapy and Biomarkers 10
-
- Lung Cancer Treatments and Mutations 37
- Lung Cancer Diagnosis and Treatment 8
- Cancer Research top 2%
- Breast Cancer Treatment Studies 19
- Otorhinolaryngology top 5%
- Molecular Biology top 10%
- Co-authors
- Tindara FranchinaAlessandro RussoGiuseppina Rosaria Rita RicciardiLucio CrinòFilippo de MarinisMaurizio TonatoGiorgio V. ScagliottiM. Marangolo
- Journals
- Journal of Clinical Oncology (17 papers)SHILAP Revista de lepidopterología (2 papers)The Journal of Immunology (1 paper)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Vincenzo Adamo
115 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 2.4k
- Pulmonary and Respiratory Medicine 2.2k
- Cancer Research 699
- Otorhinolaryngology 121
- Molecular Biology 1.0k
Countries citing papers authored by Vincenzo Adamo
This map shows the geographic impact of Vincenzo Adamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincenzo Adamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincenzo Adamo more than expected).
Fields of papers citing papers by Vincenzo Adamo
This network shows the impact of papers produced by Vincenzo Adamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincenzo Adamo. The network helps show where Vincenzo Adamo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vincenzo Adamo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 9 | |
| 3 | 2020 | 2 | |
| 4 | 2020 | 78 | |
| 5 | 2020 | 16 | |
| 6 | 2019 | 1 | |
| 7 | 2018 | 2 | |
| 8 | 2017 | 3 | |
| 9 | 2016 | 1 | |
| 10 | 2016 | 3 | |
| 11 | 2013 | 20 | |
| 12 | 2013 | 20 | |
| 13 | 2012 | 6 | |
| 14 | 2011 | 13 | |
| 15 | 2011 | 10 | |
| 16 | Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis. | 2009 | 55 |
| 17 | 2008 | 18 | |
| 18 | 2006 | 8 | |
| 19 | 2004 | 37 | |
| 20 | 1997 | 3 |
About Vincenzo Adamo
Vincenzo Adamo is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 118 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (37 papers), Cancer Treatment and Pharmacology (21 papers), HER2/EGFR in Cancer Research (20 papers), Breast Cancer Treatment Studies (19 papers), Colorectal Cancer Treatments and Studies (14 papers), Lung Cancer Research Studies (14 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Oncology (2.4k citations), Pulmonary and Respiratory Medicine (2.2k citations) and Cancer Research (699 citations). Vincenzo Adamo has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Tindara Franchina, Alessandro Russo, Giuseppina Rosaria Rita Ricciardi, Lucio Crinò, Filippo de Marinis, Maurizio Tonato, Giorgio V. Scagliotti, M. Marangolo, Giuseppe Altavilla and Cesare Gridelli. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.